Profile data is unavailable for this security.
About the company
PT Tempo Scan Pacific Tbk is an Indonesia-based company engaged in the industry of pharmaceuticals, consumer products and cosmetics. The Company’s segments include Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. The Pharmaceuticals segment conducts marketing of consumer health products consisting of over the counter; vitamin, mineral and supplement (VMS) and beverage products; nutritional products and herbal products; and prescription medicine products. The Consumer Products and Cosmetics segment markets and distributes own branded products as well as licensed cosmetics products. The Distribution Services segment distributes products to customers. The segment serves customers from various sales branches throughout Indonesia, covering pharma, modern trade, and general trade channels. It also markets and distributes its products overseas through its international business units. Its business network covers about 220 locations that consist of 47 branches.
- Revenue in IDR (TTM)13.12tn
- Net income in IDR1.18tn
- Incorporated1971
- Employees4.54k
- LocationTempo Scan Pacific Tbk PTLantai 16, Tempo Scan TowerJl. HR. Rasuna Said Kav. 3-4JAKARTA 12950IndonesiaIDN
- Phone+62 2 921888854
- Fax+62 29209999
- Websitehttps://www.temposcangroup.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai OPM Biosciences Co Ltd | 541.65bn | 145.94bn | 8.19tn | 261.00 | 56.14 | 1.70 | -- | 15.13 | 0.5704 | 0.5704 | 2.12 | 18.80 | 0.1046 | 2.19 | 3.72 | 930,836.10 | 2.80 | -- | 2.91 | -- | 57.52 | -- | 26.77 | -- | 21.86 | -- | 0.032 | -- | 38.41 | -- | 74.47 | -- | -- | -- |
| Eiken Chemical Co Ltd | 4.15tn | 306.37bn | 8.35tn | 754.00 | 25.44 | 1.48 | 15.32 | 2.01 | 78.83 | 78.83 | 1,067.99 | 1,355.09 | 0.6013 | 2.74 | 3.07 | 52,923,080.00 | 4.44 | 8.83 | 5.45 | 11.34 | 42.67 | 46.39 | 7.38 | 12.16 | 2.95 | -- | 0.0563 | 31.24 | 0.6396 | 4.34 | -7.75 | 17.07 | 0.6216 | 15.33 |
| Advanced Enzyme Technologies Ltd | 1.17tn | 265.84bn | 8.36tn | 338.00 | 31.39 | -- | 24.83 | 7.13 | 12.28 | 12.28 | 54.16 | -- | -- | -- | -- | 17,892,400.00 | -- | 11.87 | -- | 13.19 | 76.42 | 72.20 | 23.02 | 25.79 | -- | 59.04 | -- | 7.49 | 2.13 | 6.44 | -11.66 | 3.24 | 28.32 | 14.87 |
| Clarity Pharmaceuticals Ltd | 0.00 | -320.81bn | 8.58tn | -- | -- | 12.89 | -- | -- | -0.1167 | -0.1167 | 0.00 | 0.2017 | 0.00 | -- | -- | -- | -41.34 | -- | -45.22 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -3.57 | -- | -- | -- |
| Ocumension Therapeutics | 549.56bn | -847.18bn | 8.65tn | 444.00 | -- | 1.32 | -- | 15.74 | -0.6378 | -0.6378 | 0.4139 | 4.57 | 0.078 | 3.61 | 2.12 | 600,045.90 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | -- | -- |
| Tempo Scan Pacific Tbk PT | 13.12tn | 1.18tn | 8.68tn | 4.54k | 7.38 | 1.13 | 5.55 | 0.6617 | 260.77 | 260.77 | 2,908.25 | 1,706.91 | 1.16 | 4.37 | 9.03 | 2,889,820,000.00 | 11.04 | 9.56 | 15.60 | 13.12 | 35.85 | 35.91 | 9.53 | 7.85 | 2.03 | -- | 0.1216 | -- | 7.06 | 5.40 | 17.55 | 18.12 | -6.87 | -- |
| Holder | Shares | % Held |
|---|---|---|
| FIL Investment Management (Singapore) Ltd.as of 29 Feb 2024 | 14.55m | 0.32% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 8.53m | 0.19% |
| Samarang LLPas of 30 Jun 2022 | 8.00m | 0.18% |
| Niche Asset Management Ltd.as of 30 Jun 2023 | 3.17m | 0.07% |
| Segall Bryant & Hamill LLCas of 31 Mar 2024 | 1.25m | 0.03% |
| PT Manulife Aset Manajemen Indonesiaas of 31 Dec 2019 | 1.16m | 0.03% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 623.99k | 0.01% |
| Pheim Asset Management Sdn. Bhd.as of 21 Nov 2022 | 465.30k | 0.01% |
| American Century Investment Management, Inc.as of 04 Apr 2024 | 259.30k | 0.01% |
| SLGI Asset Management, Inc.as of 31 Dec 2023 | 232.20k | 0.01% |
